{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:12:38Z","timestamp":1792145558491,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"crossref","award":["R01 NS065957"],"award-info":[{"award-number":["R01 NS065957"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"name":"US Department of the Army","award":["W81XWH-12-1-0283"],"award-info":[{"award-number":["W81XWH-12-1-0283"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.neuropharm.2015.08.007","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T20:33:43Z","timestamp":1438893223000},"page":"500-509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"special_numbering":"C","title":["Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats"],"prefix":"10.1016","volume":"99","author":[{"given":"Theresa A.","family":"Lusardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran K.","family":"Akula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayla Q.","family":"Coffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Ruskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Masino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlev","family":"Boison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.08.007_bib1","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.neuint.2013.01.028","article-title":"Glial adenosine kinase \u2013 a neuropathological marker of the epileptic brain","volume":"63","author":"Aronica","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib2","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/j.1528-1167.2011.03115.x","article-title":"Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy","volume":"52","author":"Aronica","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/glia.22285","article-title":"Adenosine dysfunction in epilepsy","volume":"60","author":"Boison","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib4","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1073\/pnas.092642899","article-title":"Neonatal hepatic steatosis by disruption of the adenosine kinase gene","volume":"99","author":"Boison","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl.\u00a08","key":"10.1016\/j.neuropharm.2015.08.007_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1528-1167.2008.01846.x","article-title":"Energy metabolism as part of the anticonvulsant mechanism of the ketogenic diet","volume":"49","author":"Bough","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.seizure.2011.06.009","article-title":"Long-term follow-up of the ketogenic diet for refractory epilepsy: multicenter Argentinean experience in 216 pediatric patients","volume":"20","author":"Caraballo","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrd3955","article-title":"Adenosine receptors as drug targets\u2013what are the challenges?","volume":"12","author":"Chen","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneumeth.2008.04.019","article-title":"The pilocarpine model of temporal lobe epilepsy","volume":"172","author":"Curia","year":"2008","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.seizure.2010.06.006","article-title":"Long-term outcome and tolerability of the ketogenic diet in drug-resistant childhood epilepsy\u2013the Austrian experience","volume":"19","author":"Dressler","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib10","series-title":"Models of Seizures and Epilepsy","first-page":"415","article-title":"Kainate-induced status epilepticus: a chronic model of acquired epilepsy","author":"Dudek","year":"2006"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1528-1157.1980.tb04305.x","article-title":"Endogenously released adenosine regulates excitability in the in\u00a0vitro hippocampus","volume":"21","author":"Dunwiddie","year":"1980","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2008.04.007","article-title":"Evidence for the involvement of the adenosine A(2A) receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine","volume":"55","author":"El Yacoubi","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11011-014-9586-4","article-title":"Effects of ketogenic diets on the occurrence of pilocarpine-induced status epilepticus of rats","volume":"30","author":"Gama","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib14","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/nn1791","article-title":"2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure","volume":"9","author":"Garriga-Canut","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuint.2008.10.012","article-title":"Ketogenic diet is antiepileptogenic in pentylenetetrazole kindled mice and decrease levels of N-acylethanolamines in hippocampus","volume":"54","author":"Hansen","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib16","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1528-1167.2011.03171.x","article-title":"Neuron-restrictive silencer factor is not required for the antiepileptic effect of the ketogenic diet","volume":"52","author":"Hu","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib17","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1073\/pnas.131102898","article-title":"Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy","volume":"98","author":"Huber","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neulet.2011.12.002","article-title":"Ketogenic diet protects against epileptogenesis as well as neuronal loss in amygdaloid-kindling seizures","volume":"508","author":"Jiang","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib19","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1194\/jlr.M046755","article-title":"Ketogenic diet sensitizes glucose control of hippocampal excitability","volume":"55","author":"Kawamura","year":"2014","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(98)00410-5","article-title":"Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy","volume":"353","author":"Klitgaard","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib21","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1528-1167.2012.03716.x","article-title":"Finding a better drug for epilepsy: antiepileptogenesis targets","volume":"53","author":"Kobow","year":"2012","journal-title":"Epilepsia"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.neuropharm.2015.08.007_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1528-1167.2011.03145.x","article-title":"The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis?","volume":"52","author":"Kobow","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00401-013-1168-8","article-title":"Deep sequencing reveals increased DNA methylation in chronic rat epilepsy","volume":"126","author":"Kobow","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nurt.2009.01.005","article-title":"Ketogenic diets: evidence for short- and long-term efficacy","volume":"6","author":"Kossoff","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib25","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1528-1167.2010.02667.x","article-title":"Ketogenic diet exhibits neuroprotective effects in hippocampus but fails to prevent epileptogenesis in the lithium-pilocarpine model of mesial temporal lobe epilepsy in adult rats","volume":"51","author":"Linard","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0920-1211(02)00073-6","article-title":"Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy","volume":"50","author":"Loscher","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib27","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1124\/pr.110.003046","article-title":"Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research","volume":"62","author":"Loscher","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tins.2012.11.005","article-title":"The ketogenic diet: metabolic influences on brain excitability and epilepsy","volume":"36","author":"Lutas","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib29","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1172\/JCI57813","article-title":"A\u00a0ketogenic diet suppresses seizures in mice through adenosine A1 receptors","volume":"121","author":"Masino","year":"2011","journal-title":"J.\u00a0Clin. Inv."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib46","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/00001756-199905140-00023","article-title":"Ketogenic diet reduce spontaneous seizures and mossy fiber sprouting in the kainic acid model","volume":"10","author":"Muller-Schwarze","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13311-014-0257-2","article-title":"Past and present definitions of epileptogenesis and its biomarkers","volume":"11","author":"Pitkanen","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.neuropharm.2015.08.007_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1528-1167.2007.01063.x","article-title":"Epileptogenesis in experimental models","volume":"48","author":"Pitkanen","year":"2007","journal-title":"Epilepsia"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2015.08.007_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yebeh.2008.09.023","article-title":"Molecular and cellular basis of epileptogenesis in symptomatic epilepsy","volume":"14","author":"Pitkanen","year":"2009","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1474-4422(10)70310-0","article-title":"Mechanisms of epileptogenesis and potential treatment targets","volume":"10","author":"Pitkanen","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nbd.2010.02.005","article-title":"Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis","volume":"39","author":"Qureshi","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.eplepsyres.2008.05.001","article-title":"Anticonvulsant profile of a balanced ketogenic diet in acute mouse seizure models","volume":"81","author":"Samala","year":"2008","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1227166","article-title":"Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib37","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ana.410290404","article-title":"Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilespy","volume":"29","author":"Silver","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib38","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1046\/j.1528-1157.2002.06702.x","article-title":"Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, Maryland","volume":"43","author":"Stables","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.expneurol.2009.05.018","article-title":"Antiepileptic effects of silk-polymer based adenosine release in kindled rats","volume":"219","author":"Szybala","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib47","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1528-1157.2000.tb00275.x","article-title":"The ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy","volume":"41","author":"Todorova","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0022-3565(25)29106-6","article-title":"Anticonvulsant properties of the ketogenic diet in mice","volume":"180","author":"Uhlemann","year":"1972","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib41","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2013.11.019","article-title":"Longitudinal assessment of blood-brain barrier leakage during epileptogenesis in rats. A quantitative MRI study","volume":"63","author":"van Vliet","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2015.08.007_bib43","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1172\/JCI65636","article-title":"Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis","volume":"123","author":"Williams-Karnesky","year":"2013","journal-title":"J.\u00a0Clin. Inv."},{"issue":"Suppl.\u00a08","key":"10.1016\/j.neuropharm.2015.08.007_bib44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1528-1167.2008.01843.x","article-title":"Ketone bodies, glycolysis, and KATP channels in the mechanism of the ketogenic diet","volume":"49","author":"Yellen","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.08.007_bib45","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1203\/01.PDR.0000112032.47575.D1","article-title":"Detrimental effects of the ketogenic diet on cognitive function in rats","volume":"55","author":"Zhao","year":"2004","journal-title":"Pediatr. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815300538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815300538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T22:21:43Z","timestamp":1748557303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815300538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":47,"alternative-id":["S0028390815300538"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.08.007","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}